Wolverine
BlendHealing & recoveryAlso known as: Wolverine stack, Wolverine blend, BPC-157 + TB-500 blend
A two peptide recovery blend of BPC-157 and TB-500, commonly called the Wolverine stack.
2.What it is / mechanism
Wolverine combines BPC-157 and TB-500, two peptides studied for tissue repair. The idea is that they help healing through different but complementary paths: BPC-157 supports new blood vessel growth and gut and tendon repair, while TB-500 helps cells migrate to injured areas. The blend itself has not been tested in a trial, so what we know comes from the separate peptides. Both clear the blood within hours, so neither builds up.
3.What the evidence supports
- No / insufficient dataThe blend as a whole has been tested in a human trial.
There is no trial of the Wolverine mix. Evidence exists only for the separate peptides.
- Animal data onlyIts parts support tissue repair and recovery.
BPC-157 and TB-500 are studied mostly in animals, with limited human data. See their individual entries below.
4.Dosing
| Route(s) | subcutaneous |
|---|---|
| Typical range | Depends on the mg of each peptide in your vial. Common vials hold roughly 10 mg of each, drawn as one daily dose. As singles that maps to about 250 to 500 mcg BPC-157 daily and a few mg of TB-500 per week. |
| Frequency | Often once daily |
| Cycle guidance | Usually 6 to 12 weeks, often a loading phase then maintenance. |
| Notes | Because it is a blend, one injection gives both peptides in a fixed ratio you cannot change. If you want to run TB-500 twice weekly and BPC-157 daily, as their single protocols suggest, you would need separate vials. See the component plot below to compare how each clears. |
Component saturation
One injection of Wolverine delivers every peptide at once, but each clears at its own rate. This shows how quickly each component reaches its steady-state plateau.
Component saturation
Levels are shown as multiples of a single dose. Right after an injection you have about one dose in your blood; a short half life clears most of it within hours, so it does not stack up between injections. Widen the window to confirm it stays flat. Half lives are rough teaching estimates, not exact values.
5.Reconstitution
| Vial sizes | 10 mg, 20 mg |
|---|---|
| Diluent | Bacteriostatic water for multi dose vials, or sterile water for single use |
| Concentration | Example: a 20 mg blend vial (about 10 mg of each) plus 2 mL of water gives 10 mg/mL total, so 1 mg of the blend is 0.1 mL, which is 10 units on a U-100 syringe. Check your label, since ratios vary. |
| Notes | Sold as a pre mixed lyophilized blend, commonly around 10 to 20 mg total. The label should list the mg of BPC-157 and TB-500 separately. |
Reconstitution calculator
Pick your vial size and how much water you add to see the draw volume and syringe units for a dose. Open the full calculator →
Inputs
Reminder: 1 mg = 1,000 mcg
Total amount stated on the vial, e.g. 5 mg.
How much diluent you draw into the vial.
Target dose per injection, in mcg. 1 mg = 1,000 mcg.
Result
Draw to
5 units
= 0.05 mL on your syringe
- Concentration
- 5,000 mcg/mL
- Per unit
- 50 mcg / unit
- Doses per vial
- 40
Educational estimate only. Not medical or dosing advice. Verify every calculation independently before use.
6.Storage & stability
Lyophilized (dry)
| Temp | Freeze for long term storage, or 2 to 8 short term |
|---|---|
| Shelf life | Many months when frozen |
| Notes | Keep dry and out of light until you mix it. |
Reconstituted
| Temp | 2 to 8 (refrigerated) |
|---|---|
| Shelf life | About 2 to 4 weeks |
| Notes | Do not freeze after mixing. Discard if cloudy or discolored. |
7.Reported side effects
- WarningThe combined risks of both peptides at onceYou take on the side effects of BPC-157 and TB-500 together, in a ratio you cannot change.
- CautionInjection site reactions(common)
- CautionTiredness or head fog, mostly early in a cycle(common)Often reported in the first week, largely from the TB-500 part, then it fades.
8.Interactions & stacking risks
- SeriousActive cancer or a known tumor
Both peptides promote new blood vessel growth, which could in theory support a tumor.
9.Contraindications / who should avoid
- SeriousActive or recent cancer, or a strong family history
Both parts encourage new blood vessel growth, a theoretical concern for feeding a tumor.
- SeriousPregnancy or breastfeeding
No safety data for either part.
10.COA & purity notes
| Common adulterants | unclear or missing mg for each peptide, underdosed material, one peptide missing or swapped |
|---|---|
| Mislabeling | A good blend lists the mg of BPC-157 and TB-500 and comes with a COA. |
| Notes | Unregulated research material sold as a fixed blend. |
11.Sources
Last reviewed 2026-07-07 · status: reviewed